中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Home

Chinese Version

Online office

Journal Online

Forthcoming Articles

Current Issue

Next Issue

Earlier Issues

Download

Editorial Board [2019/7/26]

Instructions for Authors [2015/1/26]

Instructions to Contributors [2013/3/25]

Top

Top Downloaded
Top Cited

Links

alljournals

扫描微信二维码，获取更多信息

Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery

View Full Text View/Add Comment Download reader

KeyWord:Salvia miltiorrhiza composita, coronary heart disease, non heart surgery, myocardial ischemia during operation,

Author Name	Affiliation
Zhou Suning	Shandong University of TCM, 250014, Jinan
Duan Changli	Shandong University of TCM, 250014, Jinan
Wei Qing	Shandong University of TCM, 250014, Jinan
Shao Wei	Qianfoshan Mountain Hospital of Shandong Province, Jinan

Hits: 1019

Download times: 525

Abstract:

Objective: To observe the preventing and treating effect of Salvia Miltiorrhiza Compsita (SMC) in patients with ischemic coronary heart disease (CHD) undergoing non heart surgery. Methods: One hundred and eight patients were randomly divided into control group and treatment group. During operation,the control group was treated by heteropathy such as nitrate ester, while the treatment group was treated with SMC intravenously. ECG, heart rate (HR), mean arterial pressure (MAP) and sphygmous blood oxygen saturation (SpO 2) and quantity of blood loss were observed during and at the end of the operation. The efficacy of treatment was judged according to the change of ECG. Results: The total effective rate in the treatment group was 90.7% (49/54 cases), while in the control group it was 35.2% (19/54 cases). There was significant difference between the two groups ( P <0.01). HR of the patients in the treatment group was not changed significantly, but in the control group, it became faster ( P <0.05). No significant difference was found in MAP and SpO 2 between the two groups, or in comparison of data before and after operation. Also no significant difference in quantity of blood loss was shown between the two groups. Conclusion: SMC could effectively protect heart function from myocardial ischemia in patients with CHD undergoing non heart surgery, neither shows any side effect. Therefore, it is an effective and safe measure.